Search results for "chronic"

showing 10 items of 3309 documents

Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C.

2012

Under-enrolment of women to randomized clinical trials, including chronic hepatitis C, has long been recognized. The aim of this study was to identify factors predictive of sustained virological response (SVR) to PEG IFN/Ribavirin antiviral therapy in relation to gender and reproductive status of female patients involved. Seven hundred and forty-six treatment-naïve patients (431 men, 315 women) treated with Peg-IFNα-2a (180 μg/week) or Peg-IFNα-2b (1.5 μg/kg/week) plus ribavirin (800–1400 mg/day) for 24 or 48 weeks were studied between 2006 and 2010. Differences in SVR rate, overall and by gender were assessed after adjustment and propensity score matching. SVR was obtained in 44.2% of Peg-…

AdultMaleAdolescentInterferon alpha-2Antiviral AgentsPolyethylene GlycolsYoung AdultSex FactorsRibaviringenderHumansAgedSettore MED/12 - GastroenterologiaPeg IFNAge FactorsInterferon-alphaHepatitis C ChronicMiddle Agedcentral fat distribution cytokines metabolic syndrome pharmacokinetics sustained virological responseRecombinant ProteinsTreatment OutcomeDrug Therapy CombinationFemaleEpatite HCV; Peg IFN; genderMenopauseSettore SECS-S/01 - StatisticaEpatite HCVJournal of viral hepatitis
researchProduct

Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B

2008

Aims/background CD4+ T-helper cell (Th) responses to hepatitis B virus (HBV) core antigen (HBc) are increased during exacerbations in acute and chronic hepatitis B (AHB, CHB) and might influence the induction of CD8+ cytotoxic T lymphocytes (CTL) that are important for viral clearance. Methods HBc-specific proliferative responses and cytokine release of blood mononuclear cells (PBMC) were studied in patients with AHB or CHB, as well as responders and non-responders to interferon-alpha treatment (IFN-R, IFN-NR), by [3H]-thymidine-uptake, enzyme-linked immunosorbent assay (ELISA) and Elispot assay and were compared to peptide HBc18 27-specific CTL precursor frequencies among CD8+ T cells deri…

AdultMaleAdolescentLymphocyte Activationmedicine.disease_causePolymerase Chain ReactionHepatitis B ChronicmedicineHumansCytotoxic T cellHepatitis B virusHepatologybiologybusiness.industryELISPOTInterferon-alphaT-Lymphocytes Helper-InducerT helper cellMiddle AgedHepatitis Bbiology.organism_classificationmedicine.diseaseHepatitis B Core AntigensVirologyCTL*medicine.anatomical_structureHepadnaviridaeAcute DiseaseImmunologyLeukocytes MononuclearFemalebusinessCD8T-Lymphocytes CytotoxicLiver
researchProduct

Suicide attempts in chronically depressed individuals: What are the risk factors?

2020

Abstract Chronically depressed individuals have a high suicide risk. However, it is an open question whether previously observed risk factors for suicide attempts also apply to chronic depression or whether there are specific risk factors related to chronic-recurrent illness. We drew from a large group of chronically depressed individuals seeking psychotherapy to investigate demographic and psychological factors related to previous suicide attempts. Participants took part in the SCID and filled out established questionnaires. Among 368 chronically depressed individuals (68.7% women; Mage = 40.95 years), 75 participants (19.4%) reported previous suicide attempts. Men were more likely to have…

AdultMaleAdolescentPoison controlSuicide AttemptedSuicide preventionPersonality DisordersSeverity of Illness IndexSuicidal Ideation03 medical and health sciences0302 clinical medicineRisk FactorsSurveys and QuestionnairesMedicineHumansInterpersonal RelationsRisk factorBiological PsychiatryDepression (differential diagnoses)Suicide attemptbusiness.industryDepressionMiddle Agedmedicine.diseasePersonality disordersAnxiety Disorders030227 psychiatryAggressionPsychiatry and Mental healthCross-Sectional StudiesSexual abuseChronic DiseaseAnxietyFemalemedicine.symptombusinessSelf-Injurious Behavior030217 neurology & neurosurgeryClinical psychologyPsychiatry research
researchProduct

Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen.

1987

Autoantibodies against a soluble liver antigen (SLA) were detected in 23 patients with HBsAg-negative chronic active hepatitis (CAH) but not in 502 patients with various other hepatic and non-hepatic disorders or 165 healthy blood donors. Anti-SLA-positive serum samples were negative for antinuclear and liver-kidney-microsomal antibodies, markers of two subgroups of autoimmune-type CAH, 6 anti-SLA-positive patients were negative for all autoantibodies sought. Most of the anti-SLA-positive patients were young women (2 men, 21 women; mean age 37 years) with hypergammaglobulinaemia (mean 3.2 g/l, range 1.8-5.3 g/l); 18 of the 23 patients had received immunosuppressive treatment and all respond…

AdultMaleAdolescentRadioimmunoassayImmunofluorescenceAutoantigensSex FactorsAntigenImmunopathologyHypergammaglobulinemiamedicineHumansHepatitis AntibodiesAgedAutoantibodiesHepatitis ChronicHepatitisAutoimmune diseasemedicine.diagnostic_testbiologybusiness.industryfungiAutoantibodyRadioimmunoassayGeneral MedicineMiddle Agedmedicine.diseaseImmunologybiology.proteinFemaleAntibodybusinessLancet (London, England)
researchProduct

Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic…

1996

Abstract Antibodies directed to the HBs antigen indicate viral clearance and the development of life-long immunity in patients that recovered from HBV infection. In HBs antigen vaccine recipients anti-HBs antibodies provide protective immunity. However, little is known about the regulation of this HBs-specific antibody response. The existence of anti-HBs-secreting B cells was demonstrated using the highly sensitive ELISPOT technique compared with conventional ELISA in serum and cell culture supernatants. In the peripheral blood of patients with acute self-limited hepatitis B, HBs-specific B cells were demonstrated with a high frequency despite undetectable anti-HBs serum antibodies. HBV-imm…

AdultMaleAdolescentT-LymphocytesImmunologymedicine.disease_cause03 medical and health sciences0302 clinical medicineImmune systemNeutralization TestsImmunityHumansImmunology and AllergyMedicineHepatitis B VaccinesHepatitis B AntibodiesRapid PublicationsB cellAgedHepatitis Chronic030304 developmental biologyHepatitis B virusB-LymphocytesImmunity Cellular0303 health sciencesHepatitis B Surface Antigensbiologybusiness.industryELISPOTvirus diseasesMiddle AgedHepatitis BHepatitis Bmedicine.diseasebiology.organism_classificationVirologydigestive system diseases3. Good healthmedicine.anatomical_structureHepadnaviridaeAcute DiseaseImmunologybiology.proteinFemale030211 gastroenterology & hepatologyAntibodybusinessClinical and Experimental Immunology
researchProduct

Ageing, lifestyle modifications, and cardiovascular disease in developing countries.

2006

Developing countries face the double menace of still prevalent infectious diseases and increasing cardiovascular disease (CVD) with epidemic proportions in the near future, linked to demographic changes (expansion and ageing), and to urbanisation and lifestyle modifications. It is estimated that the elderly population will increase globally (over 80% during the next 25 years), with a large share of this rise in the developing world because of expanding populations. Increasing longevity prolongs the time exposure to risk factors, resulting in a greater probability of CVD. As a paradox, increased longevity due to improved social and economical conditions associated with lifestyle changes in t…

AdultMaleAgingAGEING LIFESTYLE HYPERTENSION DIABETES OBESITY CARDIOVASCULAR DISEASE CHRONIC DISEASESSettore MED/09 - Medicina InternaAdolescentInfant NewbornInfantHealth PromotionEmigration and ImmigrationMiddle AgedLife ExpectancyCardiovascular DiseasesRisk FactorsChild PreschoolHumansFemaleChildPopulation GrowthDeveloping CountriesLife StyleAged
researchProduct

Virtual reality treatment of flying phobia.

2002

Flying phobia (FP) might become a very incapacitating and disturbing problem in a person's social, working, and private areas. Psychological interventions based on exposure therapy have proved to be effective, but given the particular nature of this disorder they bear important limitations. Exposure therapy for FP might be excessively costly in terms of time, money, and efforts. Virtual reality (VR) overcomes these difficulties as different significant environments might be created, where the patient can interact with what he or she fears while in a totally safe and protected environment, the therapist's consulting room. This paper intends, on one hand, to show the different scenarios desig…

AdultMaleAircraftmedicine.medical_treatmentApplied psychologyExposure therapyPsychological interventionVirtual realitySensitivity and SpecificityFlying PhobiaUser-Computer InterfaceComputer GraphicsMedicineHumansPatient treatmentComputer SimulationElectrical and Electronic EngineeringSimulationTravelConsulting roomCognitive Behavioral Therapybusiness.industryReproducibility of ResultsGeneral MedicineFearComputer Science ApplicationsMultiple baseline designTreatment OutcomePhobic DisordersTherapy Computer-AssistedChronic DiseaseAerospace MedicinePanic DisorderFemaleUser interfaceDesensitization PsychologicbusinessBiotechnologyIEEE transactions on information technology in biomedicine : a publication of the IEEE Engineering in Medicine and Biology Society
researchProduct

Use of a comprehensive diagnostic algorithm for Anisakis allergy in a high seroprevalence Mediterranean setting

2020

Summary Background.Diagnosis of anisakis allergy (AA) is based on the skin prick test (SPT) and specific IgE (sIgE) determination. Anyway, false positivity cases are due to cross reactivity with numerous allergens. The aim of the study was to evaluate the reliability of a comprehensive diagnostic algorithm for the AA. Methods.An observational study was conducted on a sample of consecutive subjects accessing the allergology outpatient ambulatories of two hospitals located in Western Sicily. All the recruited outpatients were tested by Skin Prick Test performed using anisakis extracts by ALK-Abello (Madrid, Spain). Specific IgE dosage for anisakis extracts was then performed by using ImmunoCA…

AdultMaleAllergyAdolescentAnisakiBasophil activation testBasophil Degranulation Testmedicine.disease_causeImmunoglobulin EAnisakiasisSettore MED/42 - Igiene Generale E ApplicataCross-reactivityAnisakisYoung AdultFood allergySeroepidemiologic StudiesmedicineHypersensitivityImmunology and AllergySeroprevalenceAnimalsHumansChronic UrticariaImmunocapanisakis allergySkin TestsImmunodiagnosticsfood allergybiologybusiness.industryMediterranean RegionAllergensImmunoglobulin EMiddle Agedmedicine.diseasebiology.organism_classificationAnisakisBasophil activationItalyAntigens Helminthbiology.proteinFemalediagnosis of Anisakis sensitizationbusinessAlgorithmAlgorithms
researchProduct

No evidence for a correlation of glutathione S-tranferase polymorphisms and chronic rhinosinusitis.

2011

OBJECTIVE: Cellular detoxification mechanisms are mandatory for cellular protection against oxidative stress and reactive oxygen species. One major group of antioxidative active enzymes involved in cellular detoxification are the Glutathione S-Transferases (GST). Multiple subtypes like GSTM1, GSTP1, and GSTT1 and variants of them are known, arising from allelic variations of the GST loci. Moreover, functional variants occur in high percentages and have been associated with diseases like bronchial asthma and bronchial hyperresponsiveness. The interplay of oxidative stress, detoxifying genes like GSTs and the genesis of respiratory tract illness is under contradictory debate. In this study, w…

AdultMaleAllergyCellular detoxificationComorbidityGSTP1Nasal Polypsotorhinolaryngologic diseasesmedicineGenetic predispositionHypersensitivityHumansNasal polypsGenetic Predisposition to DiseaseSinusitisAsthmaGlutathione TransferaseRhinitisPolymorphism Geneticbusiness.industryGeneral Medicinerespiratory systemmedicine.diseaseAsthmaNasal MucosaOxidative Stressmedicine.anatomical_structureOtorhinolaryngologyGlutathione S-Transferase piBronchial hyperresponsivenessImmunologyChronic DiseaseFemalebusinessRespiratory tractRhinology
researchProduct

Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicentre study.

1990

In a multicentre trial, 82 patients known to be hepatitis B e antigen and hepatitis B virus DNA positive for at least 1 year, with elevated serum alanine aminotransferase levels and chronic liver lesions on biopsy, were randomized to receive either recombinant interferon alfa-2a at a dose of 4.5 million units thrice weekly for 4 months or no treatment. At the end of therapy, viral DNA clearance and aminotransferase normalization were significantly (p less than 0.05) more frequent in treated patients than in controls. After 16 months' follow up, the difference was still significant for hepatitis B e antigen clearance and transaminase normalization. Hepatitis B virus DNA reactivation was obse…

AdultMaleAlpha interferonInterferon alpha-2medicine.disease_causeTransaminaseLiver diseaseInterferonBiopsymedicineHumanschronic hepatitis BHepatitis B e AntigensHepatitis B virustherapyHepatitis B Surface AntigensHepatologybiologymedicine.diagnostic_testbusiness.industryInterferon-alphaAlanine TransaminaseinterferonHepatitis Bmedicine.diseaseHepatitis BRecombinant ProteinsAlanine transaminaseLiverImmunologyChronic Diseasebiology.proteinFemalechronic hepatitis B; therapy; interferonbusinessBiomarkersmedicine.drugFollow-Up StudiesJournal of hepatology
researchProduct